Fewer Doses of Prophylaxis Provides Near-Optimal Protection Against RSV

Researchers from Yale and the National Institutes of Health and the Agency for Healthcare Research and Quality reveal that fewer doses of the antibody for Respiratory Syncytial Virus can be given to children and still offer near-optimal protection. Respiratory Syncytial Virus, or RSV, is the most common cause of bronchiolitis and pneumonia in U.S. children […]
The post Fewer Doses of Prophylaxis Provides Near-Optimal Protection Against RSV appeared first on SciTech Daily.